From forums to facts
Claims Center
We do not mock the question or hide the uncertainty. Each review explains why a claim feels believable, what the evidence says, what would change the answer, and where professional care belongs.
Showing 6 of 6 evidence reviews.
"If a peptide works in animals, it probably works in people."
Animal research can reveal mechanisms and justify human studies, but it cannot establish clinical benefit, safe exposure, or the balance of benefit and harm in people.
Read the evidence review ->"Peptides are natural or already in the body, so they are safer than ordinary drugs."
A related signal may exist in the body, but that does not establish the safety of an external product, a modified sequence, repeated exposure, impurities, or use in a person with other conditions.
Read the evidence review ->"A 'research use only' label makes a peptide legal or acceptable for personal human use."
Research use only describes a stated laboratory market. It does not grant drug approval, establish a lawful clinical pathway, verify product quality, or create medical supervision.
Read the evidence review ->"BPC-157 is FDA-approved now because FDA reviewed it or because a phase 2 trial exists."
BPC-157 is not an FDA-approved drug. Agency review activity and a registered study are real developments, but neither is a marketing approval or a posted clinical result.
Read the evidence review ->"BPC-157 and TB-500 have proven synergy for injury recovery."
The pairing is common in discussions, but repeated co-use does not establish synergy. That conclusion requires a controlled comparison of each component, the combination, and a suitable control.
Read the evidence review ->"If forums and adverse-event databases show few serious reports, a peptide is probably safe."
Low report counts may reflect few events, but they may also reflect low use, underreporting, poor traceability, delayed effects, missing follow-up, or failure to connect a symptom with a product.
Read the evidence review ->